Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota

Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. D J Ballard , L L Humphrey , L J Melton, 3rd , P P Frohnert , P C Chu , W M O'Fallon and P J Palumbo Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905. Abs...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 37; no. 4; pp. 405 - 412
Main Authors D J Ballard, L L Humphrey, L J Melton, 3rd, P P Frohnert, P C Chu, W M O'Fallon, P J Palumbo
Format Journal Article
LanguageEnglish
Published American Diabetes Association 01.04.1988
Online AccessGet full text

Cover

Loading…
More Information
Summary:Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. D J Ballard , L L Humphrey , L J Melton, 3rd , P P Frohnert , P C Chu , W M O'Fallon and P J Palumbo Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905. Abstract Clinical risk factors for nephropathy were assessed in a population-based study of Rochester, Minnesota, residents with diabetes mellitus initially diagnosed between 1945 and 1969 (incidence cohort). The 1031 Rochester residents with non-insulin-dependent diabetes mellitus (NIDDM) were followed through their complete medical records in the community to 1 January 1982. The prevalence of persistent proteinuria was 8.2% at the diagnosis of NIDDM. Among those initially free of persistent proteinuria, the subsequent incidence was 15.3/1000 person-yr. Twenty years after the diagnosis of diabetes, the cumulative incidence of persistent proteinuria was 24.6%. A proportional hazards model identified the following risk factors for persistent proteinuria in NIDDM: elevated initial fasting blood glucose (P less than .01); older age at onset of diabetes (P less than .01); male gender (P = .05); and presence of macrovascular disease (P = .05), diabetic retinopathy (P = .05), or glycosuria (P = .07) at the diagnosis of diabetes. Separate analyses controlling for attained age indicated no association between duration of NIDDM and the incidence of persistent proteinuria. Stratified analysis of the two most significant risk factors (fasting blood glucose and age) indicated that hyperglycemia was a stronger risk factor for proteinuria in younger diabetic subjects, perhaps because of a competing risk of death in the elderly diabetic patient. In contrast to a recently described decreasing secular trend of proteinuria in Danish insulin-dependent diabetes mellitus patients, there was no decrease over the past 40 yr in proteinuria risk in this NIDDM incidence cohort.
ISSN:0012-1797
1939-327X
0012-1797
DOI:10.2337/diabetes.37.4.405